nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—Dactinomycin—muscle cancer	0.17	0.197	CbGbCtD
Loratadine—CYP2C8—Etoposide—muscle cancer	0.142	0.164	CbGbCtD
Loratadine—ABCB1—Vincristine—muscle cancer	0.105	0.121	CbGbCtD
Loratadine—ABCB1—Etoposide—muscle cancer	0.0962	0.111	CbGbCtD
Loratadine—ABCB1—Doxorubicin—muscle cancer	0.0656	0.0759	CbGbCtD
Loratadine—ABCB1—Methotrexate—muscle cancer	0.0636	0.0735	CbGbCtD
Loratadine—CYP3A4—Vincristine—muscle cancer	0.0629	0.0727	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—muscle cancer	0.0618	0.0715	CbGbCtD
Loratadine—CYP3A4—Etoposide—muscle cancer	0.0576	0.0667	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—muscle cancer	0.0393	0.0455	CbGbCtD
Loratadine—Drug interaction—Vincristine—muscle cancer	0.00325	0.024	CcSEcCtD
Loratadine—Cardiovascular disorder—Etoposide—muscle cancer	0.00278	0.0206	CcSEcCtD
Loratadine—Lethargy—Dactinomycin—muscle cancer	0.0025	0.0185	CcSEcCtD
Loratadine—Blister—Doxorubicin—muscle cancer	0.00176	0.013	CcSEcCtD
Loratadine—Pharyngitis—Dactinomycin—muscle cancer	0.00168	0.0124	CcSEcCtD
Loratadine—Depression—Vincristine—muscle cancer	0.00168	0.0124	CcSEcCtD
Loratadine—Alopecia—Dactinomycin—muscle cancer	0.0015	0.0111	CcSEcCtD
Loratadine—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00144	0.0107	CcSEcCtD
Loratadine—Viral infection—Doxorubicin—muscle cancer	0.0014	0.0104	CcSEcCtD
Loratadine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00137	0.0101	CcSEcCtD
Loratadine—Alopecia—Vincristine—muscle cancer	0.00134	0.0099	CcSEcCtD
Loratadine—Malaise—Dactinomycin—muscle cancer	0.00133	0.00984	CcSEcCtD
Loratadine—Hepatobiliary disease—Etoposide—muscle cancer	0.00129	0.00956	CcSEcCtD
Loratadine—Myalgia—Dactinomycin—muscle cancer	0.00126	0.00929	CcSEcCtD
Loratadine—Discomfort—Dactinomycin—muscle cancer	0.00124	0.00918	CcSEcCtD
Loratadine—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00123	0.0091	CcSEcCtD
Loratadine—Agitation—Vincristine—muscle cancer	0.00121	0.00896	CcSEcCtD
Loratadine—Hypertension—Vincristine—muscle cancer	0.00114	0.00842	CcSEcCtD
Loratadine—Myalgia—Vincristine—muscle cancer	0.00112	0.0083	CcSEcCtD
Loratadine—Immune system disorder—Etoposide—muscle cancer	0.00111	0.0082	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0011	0.00812	CcSEcCtD
Loratadine—Alopecia—Etoposide—muscle cancer	0.00108	0.00802	CcSEcCtD
Loratadine—Lethargy—Methotrexate—muscle cancer	0.00108	0.00802	CcSEcCtD
Loratadine—Anaphylactic shock—Vincristine—muscle cancer	0.00108	0.00796	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—muscle cancer	0.00105	0.00781	CcSEcCtD
Loratadine—Dysgeusia—Etoposide—muscle cancer	0.00105	0.00774	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—muscle cancer	0.00104	0.00768	CcSEcCtD
Loratadine—Pain—Dactinomycin—muscle cancer	0.00103	0.00762	CcSEcCtD
Loratadine—Hypotension—Vincristine—muscle cancer	0.00101	0.00744	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—muscle cancer	0.000992	0.00734	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—muscle cancer	0.000991	0.00733	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000984	0.00728	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00098	0.00725	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—muscle cancer	0.000979	0.00724	CcSEcCtD
Loratadine—Insomnia—Vincristine—muscle cancer	0.000973	0.0072	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—muscle cancer	0.000966	0.00715	CcSEcCtD
Loratadine—Malaise—Etoposide—muscle cancer	0.000963	0.00712	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—muscle cancer	0.000962	0.00712	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—muscle cancer	0.000952	0.00704	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—muscle cancer	0.000952	0.00704	CcSEcCtD
Loratadine—Loss of consciousness—Etoposide—muscle cancer	0.000938	0.00694	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—muscle cancer	0.000938	0.00694	CcSEcCtD
Loratadine—Cough—Etoposide—muscle cancer	0.000932	0.00689	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000929	0.00687	CcSEcCtD
Loratadine—Fatigue—Vincristine—muscle cancer	0.000927	0.00686	CcSEcCtD
Loratadine—Hypertension—Etoposide—muscle cancer	0.000922	0.00682	CcSEcCtD
Loratadine—Constipation—Vincristine—muscle cancer	0.00092	0.00681	CcSEcCtD
Loratadine—Pain—Vincristine—muscle cancer	0.00092	0.00681	CcSEcCtD
Loratadine—Chest pain—Etoposide—muscle cancer	0.000909	0.00673	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000903	0.00668	CcSEcCtD
Loratadine—Discomfort—Etoposide—muscle cancer	0.000898	0.00665	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—muscle cancer	0.00088	0.00651	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—muscle cancer	0.000871	0.00645	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—muscle cancer	0.000864	0.00639	CcSEcCtD
Loratadine—Tachycardia—Etoposide—muscle cancer	0.00085	0.00629	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—muscle cancer	0.00085	0.00629	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—muscle cancer	0.00085	0.00629	CcSEcCtD
Loratadine—Skin disorder—Etoposide—muscle cancer	0.000846	0.00626	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00084	0.00621	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—muscle cancer	0.000824	0.0061	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—muscle cancer	0.000818	0.00606	CcSEcCtD
Loratadine—Depression—Methotrexate—muscle cancer	0.000816	0.00604	CcSEcCtD
Loratadine—Hypotension—Etoposide—muscle cancer	0.000814	0.00603	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—muscle cancer	0.000814	0.00602	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—muscle cancer	0.000782	0.00579	CcSEcCtD
Loratadine—Somnolence—Etoposide—muscle cancer	0.000775	0.00573	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000774	0.00573	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—muscle cancer	0.000772	0.00571	CcSEcCtD
Loratadine—Asthenia—Vincristine—muscle cancer	0.000772	0.00571	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—muscle cancer	0.000765	0.00566	CcSEcCtD
Loratadine—Rash—Dactinomycin—muscle cancer	0.000759	0.00562	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000752	0.00557	CcSEcCtD
Loratadine—Fatigue—Etoposide—muscle cancer	0.000751	0.00556	CcSEcCtD
Loratadine—Pain—Etoposide—muscle cancer	0.000745	0.00551	CcSEcCtD
Loratadine—Constipation—Etoposide—muscle cancer	0.000745	0.00551	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—muscle cancer	0.000736	0.00545	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—muscle cancer	0.000734	0.00543	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—muscle cancer	0.000729	0.0054	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—muscle cancer	0.000718	0.00531	CcSEcCtD
Loratadine—Nausea—Dactinomycin—muscle cancer	0.000715	0.00529	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—muscle cancer	0.000713	0.00527	CcSEcCtD
Loratadine—Dizziness—Vincristine—muscle cancer	0.000711	0.00526	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—muscle cancer	0.000709	0.00524	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—muscle cancer	0.000689	0.0051	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—muscle cancer	0.000689	0.0051	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—muscle cancer	0.000685	0.00507	CcSEcCtD
Loratadine—Vomiting—Vincristine—muscle cancer	0.000684	0.00506	CcSEcCtD
Loratadine—Rash—Vincristine—muscle cancer	0.000678	0.00502	CcSEcCtD
Loratadine—Dermatitis—Vincristine—muscle cancer	0.000678	0.00501	CcSEcCtD
Loratadine—Headache—Vincristine—muscle cancer	0.000674	0.00499	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00067	0.00496	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—muscle cancer	0.000668	0.00495	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—muscle cancer	0.000664	0.00491	CcSEcCtD
Loratadine—Alopecia—Methotrexate—muscle cancer	0.000649	0.0048	CcSEcCtD
Loratadine—Nausea—Vincristine—muscle cancer	0.000639	0.00473	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—muscle cancer	0.000631	0.00467	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—muscle cancer	0.000626	0.00463	CcSEcCtD
Loratadine—Asthenia—Etoposide—muscle cancer	0.000625	0.00463	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—muscle cancer	0.000596	0.00441	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—muscle cancer	0.000593	0.00439	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—muscle cancer	0.000593	0.00439	CcSEcCtD
Loratadine—Malaise—Methotrexate—muscle cancer	0.000577	0.00427	CcSEcCtD
Loratadine—Dizziness—Etoposide—muscle cancer	0.000576	0.00426	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—muscle cancer	0.000575	0.00425	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—muscle cancer	0.000568	0.00421	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—muscle cancer	0.000562	0.00416	CcSEcCtD
Loratadine—Cough—Methotrexate—muscle cancer	0.000558	0.00413	CcSEcCtD
Loratadine—Vomiting—Etoposide—muscle cancer	0.000554	0.0041	CcSEcCtD
Loratadine—Rash—Etoposide—muscle cancer	0.000549	0.00407	CcSEcCtD
Loratadine—Dermatitis—Etoposide—muscle cancer	0.000549	0.00406	CcSEcCtD
Loratadine—Headache—Etoposide—muscle cancer	0.000546	0.00404	CcSEcCtD
Loratadine—Chest pain—Methotrexate—muscle cancer	0.000544	0.00403	CcSEcCtD
Loratadine—Myalgia—Methotrexate—muscle cancer	0.000544	0.00403	CcSEcCtD
Loratadine—Tension—Doxorubicin—muscle cancer	0.000543	0.00402	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—muscle cancer	0.000542	0.00401	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000541	0.004	CcSEcCtD
Loratadine—Discomfort—Methotrexate—muscle cancer	0.000538	0.00398	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—muscle cancer	0.000538	0.00398	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—muscle cancer	0.000522	0.00386	CcSEcCtD
Loratadine—Nausea—Etoposide—muscle cancer	0.000518	0.00383	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000514	0.0038	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—muscle cancer	0.000512	0.00379	CcSEcCtD
Loratadine—Agitation—Doxorubicin—muscle cancer	0.000509	0.00377	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—muscle cancer	0.000507	0.00375	CcSEcCtD
Loratadine—Malaise—Doxorubicin—muscle cancer	0.000499	0.0037	CcSEcCtD
Loratadine—Syncope—Doxorubicin—muscle cancer	0.000497	0.00367	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—muscle cancer	0.000489	0.00362	CcSEcCtD
Loratadine—Hypotension—Methotrexate—muscle cancer	0.000488	0.00361	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—muscle cancer	0.000487	0.0036	CcSEcCtD
Loratadine—Cough—Doxorubicin—muscle cancer	0.000483	0.00358	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—muscle cancer	0.000478	0.00354	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000476	0.00352	CcSEcCtD
Loratadine—Insomnia—Methotrexate—muscle cancer	0.000472	0.00349	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—muscle cancer	0.000471	0.00349	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—muscle cancer	0.000471	0.00349	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—muscle cancer	0.000469	0.00347	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000468	0.00346	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—muscle cancer	0.000466	0.00345	CcSEcCtD
Loratadine—Somnolence—Methotrexate—muscle cancer	0.000464	0.00343	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—muscle cancer	0.000461	0.00341	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—muscle cancer	0.000459	0.0034	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000452	0.00334	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000451	0.00333	CcSEcCtD
Loratadine—Fatigue—Methotrexate—muscle cancer	0.00045	0.00333	CcSEcCtD
Loratadine—Pain—Methotrexate—muscle cancer	0.000446	0.0033	CcSEcCtD
Loratadine—Shock—Doxorubicin—muscle cancer	0.000445	0.00329	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—muscle cancer	0.000443	0.00328	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—muscle cancer	0.000441	0.00326	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—muscle cancer	0.000439	0.00325	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—muscle cancer	0.00043	0.00318	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000427	0.00316	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—muscle cancer	0.000422	0.00312	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—muscle cancer	0.000413	0.00305	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—muscle cancer	0.000413	0.00305	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000412	0.00305	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—muscle cancer	0.000409	0.00302	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—muscle cancer	0.000406	0.003	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—muscle cancer	0.000402	0.00297	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—muscle cancer	0.000398	0.00294	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00039	0.00289	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—muscle cancer	0.00039	0.00288	CcSEcCtD
Loratadine—Pain—Doxorubicin—muscle cancer	0.000386	0.00286	CcSEcCtD
Loratadine—Constipation—Doxorubicin—muscle cancer	0.000386	0.00286	CcSEcCtD
Loratadine—Asthenia—Methotrexate—muscle cancer	0.000374	0.00277	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—muscle cancer	0.000372	0.00276	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00037	0.00273	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—muscle cancer	0.000357	0.00264	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—muscle cancer	0.000357	0.00264	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—muscle cancer	0.000357	0.00264	CcSEcCtD
Loratadine—Dizziness—Methotrexate—muscle cancer	0.000345	0.00255	CcSEcCtD
Loratadine—Vomiting—Methotrexate—muscle cancer	0.000332	0.00246	CcSEcCtD
Loratadine—Rash—Methotrexate—muscle cancer	0.000329	0.00244	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—muscle cancer	0.000329	0.00243	CcSEcCtD
Loratadine—Headache—Methotrexate—muscle cancer	0.000327	0.00242	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—muscle cancer	0.000324	0.0024	CcSEcCtD
Loratadine—Nausea—Methotrexate—muscle cancer	0.00031	0.00229	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—muscle cancer	0.000309	0.00229	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—muscle cancer	0.000299	0.00221	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—muscle cancer	0.000287	0.00213	CcSEcCtD
Loratadine—Rash—Doxorubicin—muscle cancer	0.000285	0.00211	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—muscle cancer	0.000285	0.00211	CcSEcCtD
Loratadine—Headache—Doxorubicin—muscle cancer	0.000283	0.0021	CcSEcCtD
Loratadine—Nausea—Doxorubicin—muscle cancer	0.000268	0.00199	CcSEcCtD
